INmune Bio to Participate in Baird's Biotech Discovery Series Webcast on February 13, 2024 -February 06, 2024 at 09:05 am EST

Boca Raton, Florida, Feb. 06, 2024 --  INmune Bio, Inc.  , a clinical-stage immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s disease with...

Related Keywords

University Of Florida ,Florida ,United States ,Boca Raton ,Susan Fixel ,Inmune Bio ,Malu Tansey ,Jason Nelson ,David Moss ,Company Current Reports On Form ,Exchange Commission ,Inmune Bio Inc ,Parkinson Foundation Research Center ,Company Quarterly Reports On Form ,Drug Administration ,Company Annual Report On Form ,Globe Newswire Inmune Bio Inc ,Nasdaq ,Biotech Discovery Series ,Susan Fixel Chair ,Foundation Research Center ,Early Alzheimer ,White Matter Free Water ,Dominant Negative Tumor Necrosis Factor ,Natural Killer Cell Priming Platform ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Bio Contact ,Markets ,